Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective spinal anesthesia with bupivacaine alone versus bupivacaine plus fentanyl or dexmedetomidine
IRCT20161031030601N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of bupivacaine, fentanyl and dexmedetomidine in None (3 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Motor block in dependent limb, Motor block in non-dependent limb and 2 more. Started Feb 2018; status: completed.
02
Drugs
bupivacainefentanyldexmedetomidine
Beyond the preview
Go deeper on IRCT20161031030601N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161031030601N2.